Minovia Therapeutics’ MNV-201 Granted FDA Fast Track Designation for Myelodysplastic Syndrome Read more
Novo Nordisk: Ozempic Lowers Heart Attack, Stroke, and Death Risk by 23% vs. Dulaglutide in Real-World Study Read more
VectorY and Shape Therapeutics Partner to Develop AAV5-Based Vectorized Antibodies for Neurodegenerative Diseases Read more
Wheeler Bio and MindImmune Therapeutics Partner to Support Alzheimer’s Prevention Program MITI-101 Read more